{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T13:19:59Z","timestamp":1700399999107},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1997,9,1]],"date-time":"1997-09-01T00:00:00Z","timestamp":873072000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Surgical Oncology"],"published-print":{"date-parts":[[1997,9]]},"DOI":"10.1007\/bf02303677","type":"journal-article","created":{"date-parts":[[2006,2,14]],"date-time":"2006-02-14T19:32:04Z","timestamp":1139945524000},"page":"506-510","source":"Crossref","is-referenced-by-count":6,"title":["Tourniquet infusion chemotherapy for extremity in-transit lesions in malignant melanoma"],"prefix":"10.1007","volume":"4","author":[{"given":"Constantine P.","family":"Karakousis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Kontzoglou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah L.","family":"Driscoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02303677_CR1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0022-4804(79)90090-8","volume":"26","author":"CP Karakousis","year":"1979","unstructured":"Karakousis CP, Kanter PM, Lopez R, Moore R, Holyoke ED. Modes of regional chemotherapy.J Surg Res 1979;26:134\u201341.","journal-title":"J Surg Res"},{"key":"BF02303677_CR2","first-page":"481","volume":"149","author":"CP Karakousis","year":"1979","unstructured":"Karakousis CP, Row U, Holterman DA, Kanter PM, Holyoke ED. Tourniquet infusion chemotherapy in extremities with malignant lesions.Surg Gynecol Obstet 1979;149:481\u201390.","journal-title":"Surg Gynecol Obstet"},{"key":"BF02303677_CR3","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/1097-0142(19820301)49:5<850::AID-CNCR2820490505>3.0.CO;2-2","volume":"49","author":"LP Karakousis","year":"1982","unstructured":"Karakousis LP, Kanter PM, Park HC, Sharma SD, Moore R, Ewing JH. Tourniquet infusion versus hyperthermic perfusion.Cancer 1982;49:850\u20138.","journal-title":"Cancer"},{"key":"BF02303677_CR4","unstructured":"Karakousis CP, Kontzoglou K, Driscoll DL. Tourniquet infusion (TI) chemotherapy for extremity in-transit lesions in malignant melanoma. Society of Surgical Oncology, 49th Annual Cancer Symposium, March 21\u201324, 1996, Atlanta, GA, pp 52."},{"key":"BF02303677_CR5","first-page":"213","volume-title":"Cutaneous Melanoma","author":"AS Ketcham","year":"1992","unstructured":"Ketcham AS, Moffet FL, Balch CM. Classification and staging. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong SJ, eds.Cutaneous Melanoma. 2nd ed. Philadelphia: JB Lippincott, 1992:213\u201320.","edition":"2nd ed."},{"key":"BF02303677_CR6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P. Nonparametric estimation from incomplete observations.J Am Stat Assoc 1958;53:457\u201386.","journal-title":"J Am Stat Assoc"},{"key":"BF02303677_CR7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF01556579","volume":"3","author":"ET Krementz","year":"1979","unstructured":"Krementz ET, Carter RD, Sutherland CM, Campbell M. The use of regional chemotherapy in the management of malignant melanoma.World J Surg 1979;3:289\u2013304.","journal-title":"World J Surg"},{"key":"BF02303677_CR8","first-page":"313","volume":"146","author":"L Hafstrom","year":"1980","unstructured":"Hafstrom L, Jonsson PE: Hyperthermic perfusion of recurrent malignant melanoma on the extremities.Acta Chir Scand 1980;146:313\u20138.","journal-title":"Acta Chir Scand"},{"key":"BF02303677_CR9","first-page":"52","volume":"122","author":"D Lienard","year":"1991","unstructured":"Lienard D, Lejeune FJ, Delmotte JJ, et al. High dose of rTNF-a in combination with IFN-gamma and melphalan in isolated perfusion of the limbs for melanoma and sarcoma.J Clin Oncol 1991;122:52\u201360.","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"BF02303677_CR10","first-page":"21","volume":"4","author":"D Lienard","year":"1994","unstructured":"Lienard D, Eggermont AM, Schraffordt Koops H, et al. Isolated perfusion of the limb with high-dose tumour necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) and melphalan for melanoma stage III. Results of a multi-centre pilot study.Melanoma Res 1994;4(suppl 1):21\u20136.","journal-title":"Melanoma Res"},{"key":"BF02303677_CR11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0959-8049(94)00372-C","volume":"31A","author":"JM Klaase","year":"1995","unstructured":"Klaase JM, Kroon BB, Eggermont AM, et al. A retrospective comparative study evaluating the results of mild hyperthermic versus controlled normothermic perfusion.Eur J Cancer 1995;31A:58\u201363.","journal-title":"Eur J Cancer"},{"key":"BF02303677_CR12","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/00000658-199410000-00010","volume":"220","author":"ET Krementz","year":"1994","unstructured":"Krementz ET, Carter RD, Sutherland CM, Muchmore JH, Ryan RF, Creech O Jr. Regional chemotherapy for melanoma. A 35-year experience.Ann Surg 1994;220:520\u201334.","journal-title":"Ann Surg"},{"key":"BF02303677_CR13","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0039-6109(05)70517-X","volume":"76","author":"ET Krementz","year":"1996","unstructured":"Krementz ET, Sutherland CM, Muchmore JH. Isolated hyperthermic chemotherapy perfusion for limb melanoma.Surg Clin North Am 1996;76:1313\u201331.","journal-title":"Surg Clin North Am"},{"key":"BF02303677_CR14","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/00000658-198412000-00016","volume":"200","author":"F Ghussen","year":"1984","unstructured":"Ghussen F, Nagel K, Groth W, et al. A prospective randomized study of regional extremity perfusion in patients with malignant melanoma.Ann Surg 1984;200:764\u20138.","journal-title":"Ann Surg"},{"key":"BF02303677_CR15","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/BF01658878","volume":"13","author":"F Ghussen","year":"1989","unstructured":"Ghussen F, Kruger I, Smalley RV, Groth W. Hyperthermic perfusion with chemotherapy and melanoma of the extremities.World J Surg 1989;13:598\u2013602.","journal-title":"World J Surg"},{"key":"BF02303677_CR16","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1200\/JCO.1991.9.12.2091","volume":"9","author":"L Hafstrom","year":"1991","unstructured":"Hafstrom L, Rudenstein CM, Blomquist E, et al. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. Swedish Melanoma Study Group.J Clin Oncol 1991;9:2091\u20134.","journal-title":"J Clin Oncol"},{"key":"BF02303677_CR17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF02071527","volume":"16","author":"H Schraffordt-Koops","year":"1992","unstructured":"Schraffordt-Koops H, Kroon BB, Oldhoff J, Hoekstra HJ. Controversies concerning adjuvant regional isolated perfusion from stage I melanoma of the extremities.World J Surg 1992;16:241\u20135.","journal-title":"World J Surg"},{"key":"BF02303677_CR18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/bjs.1800770716","volume":"77","author":"AL Skene","year":"1990","unstructured":"Skene AL, Bulman AS, Williams TR, Thomas JM, Westburg G. Hyperthermic isolated perfusion with melphalan in the treatment of advanced malignant melanoma of the lower limb.Br J Surg 1990;77:765\u20137.","journal-title":"Br J Surg"},{"key":"BF02303677_CR19","first-page":"39","volume":"115","author":"JM Klaase","year":"1994","unstructured":"Klaase JM, Kroon BB, van Geel AN, Eggermont AM, Franklin HR, Hart AA. Prognostic factors for tumor response and limb recurrence free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan.Surgery 1994;115:39\u201345.","journal-title":"Surgery"},{"key":"BF02303677_CR20","first-page":"564","volume":"178","author":"JM Klaase","year":"1994","unstructured":"Klaase JM, Kroon BB, van Geel AN, et al. Limb recurrence-free interval and survival in patients with recurrent melanoma of the extremities treated with nomothermic isolation perfusion.J Am Coll Surg 1994;178:564\u201372.","journal-title":"J Am Coll Surg"},{"issue":"suppl 1","key":"BF02303677_CR21","first-page":"13","volume":"4","author":"JM Klaase","year":"1994","unstructured":"Klaase JM, Kroon BB, van Geel AN, Eggermont AM, Franklin HR, van Dougen JA. Is there an indication for a double perfusion schedule with melphalan for patients with recurrent melanoma of the limbs?Melanoma Res 1994;4(suppl 1):13\u20136.","journal-title":"Melanoma Res"},{"key":"BF02303677_CR22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00008390-199404000-00008","volume":"4","author":"BA Kapteijn","year":"1994","unstructured":"Kapteijn BA, Klaase JM, van Geel AN, Eggermont AM, Kroon BB. Results of regional isolated perfusion for locally inoperable melanoma of the limbs.Melanoma Res 1994;4:135\u20138.","journal-title":"Melanoma Res"},{"key":"BF02303677_CR23","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF00299159","volume":"19","author":"PJ Bryant","year":"1995","unstructured":"Bryant PJ, Balderson GA, Mead P, Egerton WS. Hyperthermic isolated limb perfusion for malignant melanoma: response and survival.World J Surg 1995;19:363\u20138.","journal-title":"World J Surg"},{"key":"BF02303677_CR24","first-page":"467","volume":"82","author":"WM Klop","year":"1996","unstructured":"Klop WM, Vrouenraets BC, van Geel BN, et al. Repeat isolation limb perfusion with melphalan for recurrent melanoma of the limbs.J Am Coll Surg 1996;82:467\u201372.","journal-title":"J Am Coll Surg"},{"key":"BF02303677_CR25","first-page":"73","volume":"5","author":"F Lejeune","year":"1995","unstructured":"Lejeune F, Lienard D, Eggermont A, et al. Administration of high-dose tumor necrosis factor alpha by isolation perfusion of the limbs. Rationale and results.J Infusional Chemotherapy 1995;5:73\u201381.","journal-title":"J Infusional Chemotherapy"},{"key":"BF02303677_CR26","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1200\/JCO.1996.14.2.479","volume":"14","author":"DL Fraker","year":"1996","unstructured":"Fraker DL, Alexander HR, Andrich M, Rosenberg SA. Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation study.J Clin Oncol 1996;14:479\u201389.","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"BF02303677_CR27","first-page":"35","volume":"4","author":"M Vaglini","year":"1994","unstructured":"Vaglini M, Santinami M, Manzi R, et al. Treatment of in-transit metastases from cutaneous melanoma by isolation perfusion with tumour necrosis factor-alpha (TNF-alpha), melphalan and interferon-gamma (IFN-gamma). Dose-binding experience at the National Cancer Institute of Milan.Melanoma Res 1994;4(suppl 1):35\u20138.","journal-title":"Melanoma Res"},{"key":"BF02303677_CR28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0960-7404(94)90004-3","volume":"3","author":"GJ Bowers","year":"1994","unstructured":"Bowers GJ, Copeland EM. Surgical limb perfusion for extremity melanoma.Surg Oncol 1994;3:91\u2013102.","journal-title":"Surg Oncol"},{"key":"BF02303677_CR29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00000658-198901000-00011","volume":"209","author":"KI Bland","year":"1989","unstructured":"Bland KI, Kimura AK, Brenner DA, et al. A phase II study of the efficacy of diamminedichloroplatinum (cisplatin) for the control of locally recurrent and in-transit malignant melanoma of the extremities using tourniquet outflow-occlusion techniques.Ann Surg 1989;209:73\u201380.","journal-title":"Ann Surg"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02303677.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02303677\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02303677","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T19:59:37Z","timestamp":1557950377000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02303677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,9]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1997,9]]}},"alternative-id":["BF02303677"],"URL":"https:\/\/doi.org\/10.1007\/bf02303677","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,9]]}}}